This article reviewed the results of studies done on animals that assessed effects of melatonin on bladder function. Melatonin does not change strip relaxation on its own. However, pre-treatment with melatonin decreases contractile responses induced by phenylephrine, acetylcholine, bethanechol and KCl in a dose-dependent manner. The contractile responses induced by the direct calcium channel openers are significantly decreased by melatonin pre-treatment. It also binds to Ca2+-activated calmodulin, and prevents it from activating myosin light-chain kinase. It may have direct effects on ion channels which are responsible for regulating bladder contraction. Its other mode of action on bladder occurs via the brain GABAA receptor. Melatonin is an antioxidant. In bladder, treatment with melatonin prevents elevations in malondialdehyde levels, reverses changes in glutathione levels, and decreases myeloperoxidase levels compared with oxidative injury. It can normalize age induced bladder dysfunction through its antioxidant effects, inhibiting smooth muscle contractility directly and restoring impaired contractility via normalization of Ca2+ handling and sensitizations pathways. It attenuates the severity of cystitis and inflammation. Mast cell proliferation and activation are increased in cystitis, but decrease by melatonin treatment. Also, there is a decrease in expression levels of pro-inflammatory cytokines after melatonin treatment.

Keywords:
Melatonin, Bladder dysfunction, Inflammation, Antioxidant, Aging
1.
Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP: Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335-353.
2.
Coge F, Guenin SP, Fery I, Migaud M, Devavry S, Slugocki C, Legros C, Ouvry C, Cohen W, Renault N, Nosjean O, Malpaux B, Delagrange P, Boutin JA: The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor. Br J Pharmacol 2009;158:1248-1262.
3.
Harlow HJ, Weekley BL: Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. J Pineal Res 1986;3:277-284.
4.
Lucchelli A, Santagostino-Barbone MG, Tonini M: Investigation into the contractile response of melatonin in the guinea pig isolated proximal colon: the role of 5-HT4 and melatonin receptors. Br J Pharmacol 1997;121:1775-1778.
5.
Regrigny O, Delagrange P, Scalbert E, Lartaud-Idjouadiene I, Atkinson J, Chillon JM: Effects of melatonin on rat pial arteriolar diameter in vivo. Br J Pharmacol 1999;127:1666-1670.
6.
Geary GG, Duckles SP, Krause DN: Effect of melatonin in the rat tail artery: role K+ channels and endothelial factors. Br J Pharmacol 1998;123:1533-1540.
7.
Semerciöz A, Onur R, Ayar A, Orhan I: The inhibitory role of melatonin on isolated guinea-pig urinary bladder: an endogenous hormone effect. BJU Int 2004;94:1373-1376.
8.
Han JH, Chang IH, Myung SC, Lee MY, Kim WY, Lee SY, Lee SY, Lee SW, Kim KD: A novel pathway underlying the inhibitory effects of melatonin on isolated rat urinary bladder contraction. Korean J Physiol Pharmacol 2012;16:37-42.
9.
Uchida K, Aoki T, Satoh H, Tajiri O: Effects of melatonin on muscle contractility and neuromuscular blockade produced by muscle relaxants. Masui 1997;46:205-212.
10.
Reyes-Vazquez C, Naranjo-Rodriguez EB, Garcia-Segoviano JA, Trujillo-Santana JT, Prieto-Gomez B: Apamin blocks the direct relaxant effect of melatonin on rat ileal smooth muscle. J Pineal Res 1997;22:1-8.
11.
Ayar A, Kutlu S, Yilmaz B, Kelestimur H: Melatonin inhibits spontaneous and oxytocin-induced contractions of rat myometrium in vitro. Neuro Endocrinol Lett 2001;22:199-207.
12.
Ouyang H, Vogel HJ: Melatonin and serotonin interactions with calmodulin: NMR, spectroscopic and biochemical studies. Biochim Biophys Acta 1998;1383:37-47.
13.
Xu F, Li JC, Ma KC, Wang M: Effect of melatonin on hypothalamic gamma-aminobutyric acid, aspartic acid, glutamic acid, beta-endorphin and serotonin levels in male mice. Biol Signals 1995;4:225-231.
14.
Rosenstein RE, Cardinali DP: Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Res 1986;398:403-406.
15.
Rosenstein RE, Estévez AG, Cardinali DP: Time-dependent effect of glutamic acid decarboxylase activity and CI influx in rat hypothalamus. J Neuroendocrinol 1989;1:443-447.
16.
Wu FS, Yang YC, Tsai JJ: Melatonin potentiates the GABA (A) receptor-mediated current in cultured chick spinal cord neurons. Neurosci Lett 1999;260:177-180.
17.
Coloma FM, Niles LP: Melatonin enhancement of [3H]-gamma-aminobutyric acid [3H] muscimol binding in rat brain. Biochem Pharmacol 1988;37:1271-1274.
18.
Stankov B, Biella G, Panara C, Lucini V, Capsoni S, Fauteck J, Cozzi B, Fraschini F: Melatonin signal transduction and mechanism of action in the central nervous system: using the rabbit cortex as a model. Endocrinology 1992;130:2152-2159.
19.
Igawa Y, Mattiasson A, Andersson KE: Effect of GABA-receptor stimulation and blockade on micturition in normal rats and rats with bladder outflow obstruction. J Urol 1993;150:537-542.
20.
Matsuta Y, Yusup A, Tanase K, Ishida H, Akino H, Yokoyama O: Melatonin increases bladder capacity via GABAergic system and decreases urine volume in rats. J Urol 2010;184:386-391.
21.
Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Munoz-Hoyos A: Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997;408:297-300.
22.
Kilic E, Ozdemir YG, Bolay H, Kelestimur H, Dalkara T: Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 1999;19:511-516.
23.
Ross D: Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Ther 1988;37:231-249.
24.
Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
25.
Tan DX, Poeggeler B, Reiter RJ, Chen LD, Chen S, Manchester LC, Barlow-Walden LR: The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993;70:65-71.
26.
Sewerynek E, Melchiori D, Ortiz GG, Poeggeler B, Reiter RJ: Melatonin reduces H2O2-induced lipid peroxidation in homogenates of different rat brain regions. J Pineal Res 1995;19:51-56.
27.
Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A: Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 1995;293:327-334.
28.
Melchiorri D, Reiter RJ, Sewerynek E, Chen LD, Nistico G: Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. FASEB J 1995;9:1205-1210.
29.
Reiter RJ, Tan DX, Manchester LC, Qi W: Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001;34:237-256.
30.
Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA: The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003;34:1-10.
31.
Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:L271-L276.
32.
Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B: Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996;21:307-315.
33.
Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C: Melatonin is a scavenger of peroxynitrite. Life Sci 1997;60:PL169-174.
34.
Onur R, Tasdemir C, Seckin D, Ilhan N, Kutlu S, Akpolat N: Combined use of melatonin and terazosin restores bladder contractility in rabbits with partial outlet obstruction. Urology 2008;72:439-443.
35.
Ersahin M, Özdemir Z, Özsavcı D, Akakın D, Yegen BC, Reiter RJ, Sener G: Melatonin treatment protects against spinal cord injury induced functional and biochemical changes in rat urinary bladder. J Pineal Res 2012; 52:340-348.
36.
Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Yamaguchi O, Andersson KE: Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function. BJU Int 2013;112:E221-230.
37.
Shaw S, Herbert V, Colman N, Jayatilleke E: Efffect of ethanol-generated free radicals on gastric intrinsic factor and glutathione. Alcohol 1990;7:153-157.
38.
Szabo S, Nagy L, Plebani M: Glutathione, protein sulfhydryls and cysteine proteases in gastric mucosal injury and protection. Clin Chim Acta 1992;206:95-105.
39.
Reiter RJ, Tan DX, Osuna C, Gitto E: Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 2000;7:444-458.
40.
Paskaloglu K, Sener G, Kapucu C, Ayanoglu-Dülger G: Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 2004;74:1093-1104.
41.
Andersson KE, de Groat WC, McVary KT, Lue TF, Maggi M, Roehrborn CG, Wyndaele JJ, Melby T, Viktrup L: Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn 2011;30:292-301.
42.
Andersson KE, Arner A: Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004;84:935-986.
43.
Yu X, Kensler T: Nrf2 as a target for cancer chemoprevention. Mutat Res 2005;591:93-102.
44.
Surh YJ: NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr 2008;17(suppl 1):269-272.
45.
Jin W, Wang H, Yan W, Xu L, Wang X, Zhao X, Yang X, Chen G, Ji Y: Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008;2008:725174.
46.
Tripathi DN, Jena GB: Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide-induced urinary bladder injury in rat. J Pineal Res 2010;48:324-331.
47.
Hald T, Horn T: The human urinary bladder in ageing. Br J Urol 1998;82(suppl 1):59-64.
48.
Gomez-Pinilla PJ, Gomez MF, Hedlund P, Swärd K, Hellstrand P, Camello PJ, Pozo MJ, Andersson KE: Effect of melatonin on age associated changes in Guinea pig bladder function. J Urol 2007;177:1558-1561.
49.
Cardinali DP, Pevet P: Basic aspects of melatonin action. Sleep Med Rev 1998;2:175-190.
50.
Poeggeler B: Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 2005;27:201-212.
51.
Harman D: Free radical theory of aging. Mutat Res 1992;275:257-266.
52.
Drake MJ, Mills IW, Noble JG: Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 2004;171:1199-1202.
53.
Paskaloglu K, Sener G, Kapucu C, Ayanoglu-Dulger G: Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 2004;74:1093-1104.
54.
Gomez-Pinilla PJ, Gomez MF, Swärd K, Hedlund P, Hellstrand P, Camello PJ, Andersson KE, Pozo MJ: Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res 2008;44:416-425.
55.
Dobrek L, Thor PJ: The influence of melatonin and agomelatine on urodynamic parameters in experimental overactive bladder model-preliminary results. Postepy Hig Med Dosw (Online) 2011;65:725-733.
56.
Nomiya M, Sagawa K, Yazaki J, Takahashi N, Kushida N, Haga N, Aikawa K, Matsui T, Oka M, Fukui T, Andersson KE, Yamaguchi O: Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn 2012;31:185-189.
57.
Andersson KE, Arner A: Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004;84:935-986.
58.
Zhang QH, Zhou ZS, Lu GS, Song B, Guo JX: Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats. Inflammation. 2013;36:651-657.
59.
Cetinel S, Ercan F, Cikler E, Contuk G, Sener G: Protective effect of melatonin on water avoidance stress induced degeneration of the bladder. J Urol 2005;173:267-270.
60.
Kwon KJ, Kim JN, Kim MK, Lee J, Ignarro LJ, Kim HJ, Shin CY, Han SH: Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection. J Pineal Res 2011;50:110-123.
61.
Matsuoka Y, Masuda H, Yokoyama M, Kihara K: Protective effects of heme oxygenase-1 against cyclophosphamide-induced haemorrhagic cystitis in rats. BJU Int 2007;100:1402-1408.
62.
Juszczak K, Ziomber A, Machowska A, Furgala A, Dobrek L, Wyczolkowski M, Thor PJ: The ameliorating effect of exogenous melatonin on urinary bladder function in hyperosmolar bladder overactivity and its influence on the autonomic nervous system activity. Acta Medica (Hradec Kralove) 2011;54:63-68.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.